AKT activation controls cell survival in response to HDAC6 inhibition

por Kaliszczak, M, Trousil, S, Ali, T, Aboagye, E O
Publicado 2016

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth

por Kaliszczak, M, Trousil, S, Åberg, O, Perumal, M, Nguyen, Q-D, Aboagye, E O
Publicado 2013

Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance

por Kaliszczak, M, Patel, H, Kroll, S H B, Carroll, L, Smith, G, Delaney, S, Heathcote, D A, Bondke, A, Fuchter, M J, Coombes, R C, Barrett, A G M, Ali, S, Aboagye, E O
Publicado 2013